CN107411062A - 枸杞瘦身酵素 - Google Patents
枸杞瘦身酵素 Download PDFInfo
- Publication number
- CN107411062A CN107411062A CN201710347170.0A CN201710347170A CN107411062A CN 107411062 A CN107411062 A CN 107411062A CN 201710347170 A CN201710347170 A CN 201710347170A CN 107411062 A CN107411062 A CN 107411062A
- Authority
- CN
- China
- Prior art keywords
- matrimony vine
- kilograms
- fat
- blood
- weight reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000241838 Lycium barbarum Species 0.000 title claims abstract description 37
- 235000015459 Lycium barbarum Nutrition 0.000 title claims abstract description 34
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 22
- 244000298479 Cichorium intybus Species 0.000 claims abstract description 16
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 16
- 235000007625 naringenin Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 6
- 230000004151 fermentation Effects 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 claims description 13
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 claims description 13
- 229940117954 naringenin Drugs 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 239000000203 mixture Substances 0.000 abstract description 10
- 230000036772 blood pressure Effects 0.000 abstract description 7
- 230000001093 anti-cancer Effects 0.000 abstract description 5
- 230000001151 other effect Effects 0.000 abstract description 5
- 230000009977 dual effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 235000001497 healthy food Nutrition 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 2
- 238000011081 inoculation Methods 0.000 abstract description 2
- 238000005360 mashing Methods 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 238000001291 vacuum drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 235000019197 fats Nutrition 0.000 description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 17
- 238000011160 research Methods 0.000 description 15
- 150000002632 lipids Chemical class 0.000 description 14
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000002218 hypoglycaemic effect Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 208000008589 Obesity Diseases 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 235000015468 Lycium chinense Nutrition 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- -1 carrotene Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 102000019280 Pancreatic lipases Human genes 0.000 description 3
- 108050006759 Pancreatic lipases Proteins 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229940116369 pancreatic lipase Drugs 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 244000276331 Citrus maxima Species 0.000 description 2
- 235000001759 Citrus maxima Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SWGKAHCIOQPKFW-JTNORFRNSA-N Caftaric acid Chemical compound OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-JTNORFRNSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000208947 Cynara Species 0.000 description 1
- 235000003198 Cynara Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 244000181025 Rosa gallica Species 0.000 description 1
- 235000000533 Rosa gallica Nutrition 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- SWGKAHCIOQPKFW-GHMZBOCLSA-N caffeoyltartaric acid Natural products OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-GHMZBOCLSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000006193 cichoric acid Nutrition 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 229950009125 cynarine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- VJQAFLAZRVKAKM-QQUHWDOBSA-N lactucin Chemical compound O[C@@H]1CC(C)=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 VJQAFLAZRVKAKM-QQUHWDOBSA-N 0.000 description 1
- VJQAFLAZRVKAKM-UHFFFAOYSA-N lactucine Natural products OC1CC(C)=C2C(=O)C=C(CO)C2C2OC(=O)C(=C)C21 VJQAFLAZRVKAKM-UHFFFAOYSA-N 0.000 description 1
- 230000020958 lipid digestion Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000009805 platelet accumulation Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
枸杞瘦身酵素属于健康食品或保健食品，尤以天然药食两用植物枸杞、洋蓟果、蔷薇果、菊苣、柚皮素等原料加工而成的一种新产品，该产品具有瘦身瘦身、降血压、降血脂、通便、抗癌等功效，该产品制作工艺：清洗打浆、混合搅拌、酶解过滤、均质杀菌、接种发酵、真空干燥、粉碎、检验包装。
Description
一、技术领域：本发明属于健康食品或保健食品，尤以天然药食两用植物枸杞、洋蓟果、蔷薇果、菊苣、柚皮素等原料，采取生物技术加工而成的健康食品或保健食品
二、背景技术：本发明以枸杞、洋蓟果、蔷薇果、菊苣、柚皮素等原料加工而成的一种新产品，该产品具有瘦身瘦身、降血压、降血脂、降血糖、通便排毒，另外还具有美容养颜、抗癌等功效。目前市场上还没有同类产品，创新研发该产品可为给瘦身瘦身的人群提供了一种新产品。该产品以纯天然药食两用植物和营养品和生物活性成分为原料制成的瘦身瘦身酵素、纯度高、吸收好、生物活性强、无任何副作用、服用方便、效果明显适应于各年龄段的瘦身人群服用。
三、发明内容：肥胖是一种营养代谢综合失调性疾病和低度全身慢性炎症。研究发现，肥胖病因相当复杂，不仅有明显的遗传性，还与饮食和运动密切相关。在今天肥胖已成为一个社会严重的共公卫生问题。
世界卫生组织(WHO)认为，肥胖与艾滋病、吸毒、凶酒并列为世界四大社会问题，医学界称之为人类死亡率高的癌症，冠心病、糖尿病、高血压、高血脂、心脑血管疾病都与肥胖直接有关。
随着我国经济的快速发展，人民生活水平的不断提高，肥胖正在成为一个关注的流行病。根据世界卫生组织的统计数学显示，全球超重人数超过10亿多，有3亿多人严重肥胖，而发展中国家的肥胖比例大幅增加。在我国根据***、科技部和国家***公布的营养与健康状况调查结果显示，我国13亿人口中有2亿人超重，特别是儿童超重迅速增长。预计今后肥胖患病率还将会有较大幅度的增长，肥胖会给国民健康造成严重的威胁，也会给个人和社会带来沉重的经济负担。
四、原料配方：枸杞20-80千克、洋蓟果30-90千克、蔷薇果10-50千克、菊苣15-60千克、柚皮素10-15千克为原料。
五、技术方案：
(一)、枸杞：(Lyciam barbarnm extraat)，枸杞是生长在青藏高原绿色生态环境，纯天然珍品药食两用植物枸杞干燥果实。枸杞是一种稀有珍贵的原生态高端滋补品。枸杞为茄科植物枸杞成熟果实。性平，味甘。归肝、肾经。具有滋补肝肾、益精明目、润肺的功效。用于虚劳精亏、腰膝酸痛、眩晕耳鸣、内热消渴、血虚萎黄、提高视力、目昏不明等。现代医学研究认为，枸杞具有增强免疫力、抗疲劳、降血压、降血脂、降血糖、保护肝脏、减肥、抗衰老、抗癌等功能。
化学成分：枸杞含多糖、氨基酸、甜菜碱、胡萝卜素、维生素B、维生素C、烟酸等多种维生素以及锰、铬、锌、铜、镁、钙、锗、钴等微量元素。
药理作用：1、降脂减肥：一项研究发现，食用枸杞具有显著的减肥效果，研究表明吃高脂肪食物时食用枸杞可以是体重增加幅度降低1/5。连续3个月给两组实验鼠喂食高脂肪食物，一组实验鼠喝水，另一组实验鼠喂食枸杞。实验对比发现，吃高脂食物同时喂食枸杞的实验鼠，3个月后，体重增加幅度比其他实验鼠少18％。枸杞之所以具有显著的减肥功效，是因为枸杞含有丰富的多糖，可分别抑制脂肪细胞，巨噬细胞和血管内皮细胞，因而发挥降血脂、抗肥胖、抗炎、和抗糖尿病的独特功效而实现减肥的。
2、保护肝脏、抗脂肪肝：枸杞提取物对保护肝脏和抗脂肪肝具有一定的作用。现代医学研究发现，枸杞中含有一种有效成分-甜菜碱，它对治疗肝脏疾病很有效。实验表明，甜菜碱有抑制脂肪在肝细胞内沉积，促进肝细胞再生的作用。另外，枸杞的中甜菜碱能防止肝脏内过多的脂肪贮存，有防脂肪肝的作用，据报道，长期经大鼠饲喂水提取物或甜菜碱饲料对ccl4引起的肝损害有保护作用，能明显降低转氨酶及肝中脂质的变化，可抑制肝中脂质沉积及促进肝细胞新生，对肝脏脂质过氧化损伤有明显的保护作用。
3、降血脂、防治动脉硬化：枸杞提取物动物及临床实验均具有良好的降血脂作用。多糖对高血脂家兔的血脂有明显的作用，能明显降低血清胆固醇及三酰甘油的含量。枸杞还可降低大鼠血胆固醇，并明显抑制灌喂胆固醇和猪油的家兔血清胆固醇升高，还具有抗动脉硬化的作用。
4、降血压和保护心脑血管：血管中的弹性纤维逐渐氧化***，是导致高血压的主要原因。枸杞可通过提高血管弹性而降低血压。实验证明，枸杞提取物能降低血液中胆固醇水平，减少血管壁上胆固醇沉积及抑制血管紧张素酶活性来降低血压。另有研究，在大鼠饲料中添加枸杞提取物、铬、锌成分，而实验组血压明显低于对照组，其机理是枸杞提取物降低了自由基的形成，改善胰岛素的敏感性。
5、抗氧化：枸杞具有良好的抗氧化作用。枸杞能抑制血浆中的脂质过氧化自由基生成作用，又能阻断脂质过氧化作用。在保护DNA、蛋白质和膜结构免遭氧化损伤起着重要作用，已知人体晶状体、角膜及玻璃体中的超氧化物歧化酶活性低，老年人血浆和组织，这是一种维持机制减弱，可能是老年人血浆过氧化脂质含量增高。
6、降血糖：防治继发性糖尿病：枸杞提取物具有显著的降血糖和防治糖尿病的功能。研究表明，枸杞多糖对正常小鼠的血糖和糖耐量的影响以及对四氧嘧啶致高血糖小鼠的保护作用表明，分别给正常小鼠灌喂一定量的枸杞多糖，其结果使血糖明显降低。糖耐量实验表明，一定量的枸杞多糖可明显对抗正常小鼠给予一定量葡萄糖引起的血糖升高。研究明显，枸杞多糖对正常及糖尿病模型动物均有降血糖作用。另据研究，枸杞可有效控制餐后血糖，明显降低餐后血糖峰值，从而形成血糖峰值期胰岛素的需求量，减轻胰岛素细胞分泌胰岛素的负荷，从而达到保护胰岛素细胞的作用。长期服用还能降低空腹血糖的作用。实验表明，无论对正常人，还是对糖耐量降低者服用后都可以降低餐后血糖峰值和降低餐后血糖水平，防止继发性糖尿病。
7、增强免疫力：小鼠灌服水提取物或肌注醇提取物均能显著增强其网状内皮***对印度墨汁的吞噬能力。水提取物或枸杞多糖均能促进小鼠腹腔巨噬细胞吞噬功能和血清中溶菌酶活性。给正常或老年小鼠灌服或腹枸杞多糖，能显著增强腹腔巨噬细胞c3b和Fc的受体数和活力，可使老年小鼠抑制性T细胞调节抗体功能恢复到成年小鼠的水平。枸杞多糖纯品比粗品具有更显著的免疫应答效应，各项免疫指标(包括非特异性免疫的免疫器官质量、巨噬细胞吞噬作用、特异性体液免疫的血清溶血素，特异性细胞免疫中的退发型***反应、淋巴细胞转化率、E玫瑰花结形成等)均有显著的差异。
(二)洋蓟果(cynara scolymusl)，为菊科菜蓟属多年生草本植物的果实。性平、味苦、甘，归肝、肾径。具有滋补肝肾、强筋骨、祛风湿、养血安胎等功效。现代药理研究表明，洋蓟果有减肥、降血脂、降血压、降血糖、利尿、镇静、保护肝脏、舒张冠脉血管、增加管脉血流量、抗病毒等作用。
化学成分：含有蛋白质、脂肪、碳水化合物、黄酮类化合物、菜蓟素，多种维生素和矿物质等成分。
药理作用：1、减肥降脂：研究发现，洋蓟果中含有的黄酮可直接作用于脂肪细胞，加快脂肪分解燃烧并产生热量，同时还能抑制脂肪在肠道内吸收，有效减少体脂含量，防止脂肪在腹部堆积，从而有效控制体重，具有减肥作用。
(三)蔷薇果，为蔷薇科树植物的果实，又称玫瑰果，含有丰富的多种营养成分有减肥瘦身的功效。研究发现，蔷薇果另含有的活性成分可以刺激葡萄糖的代谢，具有很好的减肥瘦身功效。蔷薇果含有的有机酸为机体三羧抑制循环的中间产物，参与人体代谢和能量转换，来达到减肥的目的。这也是蔷薇果含有的多种活性营养成分的综合作用，具有显著的减肥功效。
(四)菊苣(chicofy)，为多年生草本植物菊苣的地上部分，性凉、味微苦、成。具有清肝利胆、理气、健胃消食、生津祛痰、腹部胀痛、食欲不振等功效。现代医学研究认为，菊苣具有减肥、降血糖、利尿消肿、降血脂、通便等作用。
化学成分：菊苣含有马栗树皮素、山莴苣素、菊苣酸、咖啡酰酒石酸、绿原酸，块根中含有50％左右的菊糖等成分。
药理作用：1、减肥：菊苣含有丰富的菊糖，菊糖为可溶性膳食纤维，能在胃中吸水膨胀形成黏膜胶体，使人产生饱腹感并能延长胃的排空时间，从而减少食物摄入量和减少食物在小肠的时间，还能在小肠与蛋白质、脂肪等物质形成复合物，不利于这些物质的吸收，从而达到减肥的目的。另外，菊糖还能吸收胆汁酸，降低胆固醇的合成吸收，所以来达到减肥。
2、降血糖：研究表明，糖尿病人服用菊苣后不但不会加重餐后高血糖，而且还可以改善患者的葡萄糖耐量和对胰岛素的敏感性，因此具有降血糖作用。
3、降血脂：研究数据显示，菊苣可以降低血清总胆固醇和低密度脂蛋白胆固醇，改善血脂。其机理是因为菊苣作用为菊糖可吸收肠内脂肪，形成脂肪与菊糖复合物随粪便排出体外，有助于血脂水平降低。
4、防治便秘：菊苣中含有的菊糖，能使大肠蠕动，有利于大肠内容物向大肠运动，增加排便次数，有利粪便排出。同时菊糖还具有很强的吸水性，增加大便中的含水量，由此导致大便***，因而使排便变得轻松。
(五)柚皮素(Naringenin naningetol)，为柑桔类果实皮的有效成分，柚皮素是柚皮甙的甙元，属于二氢黄酮化合物，具有广泛的生理活性。有减肥、降血脂、降血糖、清除自由基、抑制血小板聚积、抗动脉粥样硬化、预防和治疗肝病、抗炎、抗菌、止咳化痰、解痉利胆、抗癌抗肿瘤等作用。
化学成分：二氢黄酮
生理功能：1、减肥瘦身：研究表明，胰脂肪酶是水分解膳食中脂质的主要消化酶，通过抑制胰脂肪酶的活性，减少或抑制外原性脂类的消化吸收，是治疗和改善肥胖作用机理之一。研究证实，柚皮素具有抑制胰脂肪酶的活性作用，可减少食物中能量的生物利用以及脂质消化与吸收，对治疗肥胖症具有显著的作用。
2、降血脂：动物实验证实，给小鼠灌服柚皮素后检测其血液中胆固醇、低密度脂蛋白、高密度脂蛋白、甘油三酯等指标。实验结果表明，柚皮素具有显著的降低血液中胆固醇、甘油三酯和低密度脂蛋白，升高高密度脂蛋白，从而达到降血脂的作用。
3、抗炎：给大鼠灌服柚皮素溶液，能显著的抑制植入羊毛球引起的发炎，各剂量组均有抗炎作用。随剂量增加抗炎效果明显增加。
4、降血糖与治疗糖尿病：研究表明，柚皮素能提高人体对胰岛素的敏感性，并能保持健康的体重，具有防治糖尿病的功效。另据报道，以色列研究发现，柚皮素与目前两种治疗2型糖尿病的药物有相同的功效。
综上所述，本产品具有减肥瘦身、降血压、降血脂、通便排毒，抗癌等功效。
六、制作工艺
1、清洗打浆：先将配方中的原料分别清洗干净，送入打浆机打成果浆。
2、混合搅拌：将各种原料果浆混合后，充分搅拌均匀。
3、酶解过滤：将混合后的果浆加入1-5％的酶解后进行过滤。
4、均质杀菌：将过滤后的果浆加热到40-80度均质，又加热到80-120度杀菌5-20分钟。
5、接种发酵：将杀菌后的果浆添加1-5％的菌种，温度保持在20-30度发酵30-180天。
6、干燥：将发酵后的果浆送入低温真空干燥机进行干燥。
7、粉碎：将干燥后果浆发酵物粉碎为80-120目粉末。此工序得水果酵素半成品。
8、检验包装：将水果酵素半成品检验合格，包装为成品。
七、质量标准：
1、理化指标：
| 枸杞酵素 | g/100g | 30 |
| 洋蓟果酵素 | g/100g | 20 |
| 蔷薇果酵素 | g/100g | 15 |
| 菊苣酵素 | g/100g | 30 |
| 柚皮素酵素 | g/100g | 5 |
2、服用方法：每日3次，每次0.5-2.0克。
3、适应人群：适应于各个年龄段的减肥人群和少年儿童。
八、实施例：取枸杞20-80千克、洋蓟果30-90千克、蔷薇果10-50千克、菊苣15-60千克、柚皮10-15千克素为原料。经过将上述原料分别清洗干净，送入打浆机打制成果浆，并混合搅拌均匀，加入1-5％的酶解后进行过滤，加热到40-80度均质后又加热到80-120度杀菌5-20分钟，添加1-5％的菌种温度保持在20-30度发酵30-180天，送入低温真空干燥机真空度0.096千帕，温度控制在30-50度进行真空干燥，干燥后粉碎为80-120目的粉末，经检验合格，包装为成品。
Claims (1)
1.枸杞瘦身酵素的制作工艺，其特征为：枸杞20-80千克、洋蓟果30-90千克、蔷薇果10-50千克、菊苣15-60千克、柚皮素10-15千克为原料，经过将上述原料分别清洗干净，送入打浆机打制成果浆，并混合搅拌均匀，加入1-5％的酶解后进行过滤，加热到40-80度均质后又加热到80-120度杀菌5-20分钟，添加1-5％的菌种温度保持在20-30度发酵30-180天，送入低温真空干燥机真空度0.096千帕，温度控制在30-50度进行真空干燥，干燥后粉碎为80-120目的粉末，经检验合格，包装为成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710347170.0A CN107411062A (zh) | 2017-05-17 | 2017-05-17 | 枸杞瘦身酵素 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710347170.0A CN107411062A (zh) | 2017-05-17 | 2017-05-17 | 枸杞瘦身酵素 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107411062A true CN107411062A (zh) | 2017-12-01 |
Family
ID=60425992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710347170.0A Pending CN107411062A (zh) | 2017-05-17 | 2017-05-17 | 枸杞瘦身酵素 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107411062A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108142881A (zh) * | 2018-03-20 | 2018-06-12 | 爱可道生物科技有限公司 | 一种洋蓟花蕾提取物降血压胶囊制品及其生产工艺 |
| CN109329531A (zh) * | 2018-12-21 | 2019-02-15 | 张建荣 | 一种洋蓟茶及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080021418A1 (en) * | 2003-07-29 | 2008-01-24 | Kao Corporation | Lipolysis stimulator |
| CN103931828A (zh) * | 2014-02-28 | 2014-07-23 | 万客齐食品（云南）有限公司 | 一种朝鲜蓟茶及其制备方法 |
| CN104187602A (zh) * | 2014-06-30 | 2014-12-10 | 青海圣烽生物技术开发有限公司 | 一种枸杞酵素的制备方法 |
| CN104642078A (zh) * | 2013-11-25 | 2015-05-27 | 邵艳艳 | 一种胶东地区日光温室芽球菊苣无土栽培技术 |
| CN105211864A (zh) * | 2015-10-28 | 2016-01-06 | 青海尤尼克生物技术有限公司 | 一种黑果枸杞混合水果酵素及其制备方法 |
-
2017
- 2017-05-17 CN CN201710347170.0A patent/CN107411062A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080021418A1 (en) * | 2003-07-29 | 2008-01-24 | Kao Corporation | Lipolysis stimulator |
| CN104642078A (zh) * | 2013-11-25 | 2015-05-27 | 邵艳艳 | 一种胶东地区日光温室芽球菊苣无土栽培技术 |
| CN103931828A (zh) * | 2014-02-28 | 2014-07-23 | 万客齐食品（云南）有限公司 | 一种朝鲜蓟茶及其制备方法 |
| CN104187602A (zh) * | 2014-06-30 | 2014-12-10 | 青海圣烽生物技术开发有限公司 | 一种枸杞酵素的制备方法 |
| CN105211864A (zh) * | 2015-10-28 | 2016-01-06 | 青海尤尼克生物技术有限公司 | 一种黑果枸杞混合水果酵素及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 朱宇: "葡萄柚或有助于治疗糖尿病", 《科技导报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108142881A (zh) * | 2018-03-20 | 2018-06-12 | 爱可道生物科技有限公司 | 一种洋蓟花蕾提取物降血压胶囊制品及其生产工艺 |
| CN109329531A (zh) * | 2018-12-21 | 2019-02-15 | 张建荣 | 一种洋蓟茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101695376B (zh) | 预防糖尿病的保健食品 | |
| CN100356867C (zh) | 黑木耳保健食品的制备方法 | |
| CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
| CN106261763A (zh) | 一种谷物膳食纤维代餐粉及其制备方法 | |
| CN106072527B (zh) | 一种排毒养颜的纳豆组合物及其制备方法 | |
| CN102919330B (zh) | 一种松花粉纤维饼干 | |
| CN106901118B (zh) | 具有辅助降血糖作用的固体饮料及其制备方法 | |
| CN101238893B (zh) | 一种高膳食纤维鹰嘴豆营养粉及其制备方法和用途 | |
| CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
| CN102197837B (zh) | 一种沙棘纤维饼干 | |
| CN109907221A (zh) | 一种具有抗氧化杂粮营养面粉以及制备方法 | |
| CN108991078A (zh) | 一种防控富贵病的桑叶食品及其制备方法 | |
| CN102150852B (zh) | 一种排毒养颜方便食品及其制备方法 | |
| CN108174951A (zh) | 一种辅助降血糖的桑叶黄精茶制备方法 | |
| CN107223846A (zh) | 一种适合中老年人的杂粮保健粉 | |
| CN106982885A (zh) | 一种罗汉果饼干及其制备方法 | |
| CN101946895A (zh) | 一种以泥鳅为主料的功能食品及其制备方法 | |
| CN107411062A (zh) | 枸杞瘦身酵素 | |
| CN105707681A (zh) | 一种具有降血糖功能的超微黑木耳粉营养粥及其制备方法 | |
| CN105613882A (zh) | 黑青稞降糖茶（奶茶） | |
| CN107048160A (zh) | 一种糖尿病人适用的果蔬米粉制品及其制备方法 | |
| CN106174286A (zh) | 高级金枸杞营养果酱 | |
| CN107927096A (zh) | 适合糖尿病人群食用的低血糖生成值的饼干及其制备方法 | |
| CN106035686A (zh) | 超级藜麦养生植物奶 | |
| CN109620858A (zh) | 防治糖尿病的药食同源制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination |